Last reviewed: June 1, 2026

Last updated: June 1, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Compounded semaglutide stability beyond 28 days depends on storage conditions, formulation composition, and manufacturer specifications from your licensed 503A pharmacy. Most compounded semaglutide products from reputable compounding pharmacies come with specific stability data that guides whether use after 28 days is appropriate.

Understanding storage requirements and stability timelines matters because improper storage or use of degraded medication may reduce efficacy or introduce safety concerns. PlexusDx emphasizes personalized precision wellness, which includes ensuring your compounded medication maintains pharmaceutical integrity throughout your treatment course.

How Stability Windows Are Determined for Compounded Semaglutide

Compounded semaglutide stability is established through pharmaceutical testing that measures how the active ingredient and formulation components degrade under specific temperature and humidity conditions. Licensed 503A compounding pharmacies base their expiration and use-by dates on this empirical data, not arbitrary timeframes.

The 28-day window often cited reflects standard refrigerated storage at 2–8°C. However, stability may extend beyond this period if the product remains properly sealed, undisturbed, and stored at correct temperatures. Your compounding pharmacy provides specific stability documentation with each prescription.

Storage Conditions That Affect Post-28-Day Viability

Temperature fluctuations, light exposure, humidity, and air exposure are the primary factors determining whether compounded semaglutide remains safe beyond 28 days. Consistency in storage conditions is more important than the absolute time elapsed since dispensing.

Storage Factor Impact on Stability
Temperature at 2–8°C (refrigerator) Optimal; supports extended viability if maintained consistently
Temperature above 8°C or room temperature Accelerates degradation; reduces stability window significantly
Freezing (below 0°C) May alter formulation; check pharmacy guidance before freezing
Exposure to light or air Oxidation and potency loss; sealed vials maintain integrity longer
Humidity fluctuations Can promote microbial growth or component separation; consistent storage preferred

What Your Compounding Pharmacy Documentation Should Include

A reputable 503A compounding pharmacy provides written stability documentation, expiration dates, and specific storage instructions with every semaglutide prescription. This documentation is not merely a suggestion; it reflects real pharmaceutical data about how that specific formulation degrades.

Before using compounded semaglutide beyond 28 days, check the vial label, packaging insert, or documentation from your pharmacy. If your provider and pharmacy confirm extended use is appropriate for your specific product and storage conditions, this clarification should be documented in your treatment record.

When to Consult Your Provider About Storage and Use Duration

If you are uncertain whether your compounded semaglutide remains appropriate to use beyond 28 days, contact your prescribing provider or compounding pharmacy before administration. Do not rely on visual inspection alone; compounded medications may appear unchanged while potency degrades.

Patients with specific genetic predispositions affecting GLP-1 receptor sensitivity, insulin response, or medication metabolism may benefit from discussing how consistent medication integrity supports treatment outcomes. Gaps in therapy due to expired or degraded medication can complicate dose escalation and efficacy assessment.

How PlexusDx Supports a More Personalized Approach

The Precision Peptide Genetic Test may help provide context around your genetic predispositions in GLP-1 receptor pathways and metabolic response factors. Understanding variants such as GLP1R rs6923761 and FTO rs9939609 can inform your provider's discussion about whether consistent, uninterrupted access to active medication—through proper storage and appropriate use windows—supports your treatment goals.

Genetic predispositions revealed by the Precision Peptide Genetic Test are not predictions of exact medication response, but they can highlight whether your metabolic profile benefits from strict adherence to protocol and medication integrity. Degraded or expired medication introduces variability that complicates clinical assessment and may delay dose optimization.

Discussing your genetic and biomarker context with your provider allows for a more informed conversation about compounded semaglutide stability, use windows, and how maintaining medication integrity fits into your personalized treatment plan. This precision-wellness approach helps ensure you receive consistent, active medication aligned with your clinical goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $229-$309/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves